Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market Outlook: Growth and Forecast Highlights 2030
Uncover key drivers, emerging technologies, and competitive movements shaping the messenger ribonucleic acid (mrna) synthesis and manufacturing market from 2026–2035 with trusted insights from The Business Research Company
How is the Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market size predicted to change over the forecast window of 2026–2035?
The messenger ribonucleic acid (mRNA) synthesis and manufacturing market size has experienced rapid expansion in recent years. It is projected to increase from $5.14 billion in 2025 to $5.79 billion in 2026, achieving a compound annual growth rate (CAGR) of 12.6%. This historical growth can be linked to factors such as the restricted availability of mRNA synthesis platforms, the initial phases of research in mRNA therapeutics, a reliance on small-scale laboratory production, emerging regulatory frameworks, and the elevated expense associated with purification and formulation services.
The messenger ribonucleic acid (mrna) synthesis and manufacturing market size is expected to experience substantial growth in the upcoming years. It is projected to expand to $9.22 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 12.3%. This expansion over the forecast period stems from factors such as technological progress in automated mRNA synthesis, the enlargement of commercial-scale mRNA manufacturing sites, increased capital investment in vaccine and therapeutic pipelines, a growing requirement for self-amplifying mRNA and new formulations, and an increase in preclinical and clinical research partnerships. Significant trends expected during this period include the rising adoption of GMP-compliant mRNA synthesis, an escalating need for large-scale mRNA production, the broadening of mRNA therapeutics and vaccine development pathways, a greater emphasis on purification, capping, and tailing services, and the increasing incorporation of mRNA-LNP formulations and stability testing.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25832&type=smp
Which Drivers Are Contributing To The Expansion Of The Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market?
The market for messenger ribonucleic acid (mRNA) synthesis and manufacturing is anticipated to expand, driven by the rising occurrence of infectious diseases. These diseases are conditions resulting from pathogenic microorganisms like bacteria, viruses, fungi, or parasites, encompassing illnesses such as malaria, which can disseminate either directly or indirectly. The surge in infectious disease prevalence stems from rapid urbanization, fostering greater population density and close human interaction, thus aiding infection transmission. mRNA synthesis and manufacturing contribute to combating these diseases by allowing for quick development and scalable production of precise vaccines and treatments designed to elicit a specific immune response. As an illustration, the World Health Organization, an international public health entity based in Switzerland, reported in October 2024 that new tuberculosis diagnoses reached approximately 8.2 million individuals in 2023, an increase from about 7.5 million in 2022, confirming tuberculosis as the primary fatal infectious disease. Consequently, the expanding incidence of infectious diseases is a key factor propelling the messenger ribonucleic acid (mRNA) synthesis and manufacturing market forward.
What Segment Classifications Make Up The Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market?
The messenger ribonucleic acid (mrna) synthesis and manufacturing market covered in this report is segmented –
1) By Service Type: Messenger Ribonucleic Acid (mRNA) Drug Synthesis, Messenger Ribonucleic Acid (mRNA) Vaccine Synthesis
2) By Scale Of Operation: Preclinical, Clinical, Commercial
3) By Therapeutic Area: Infectious Diseases, Oncology, Other Therapeutic Areas
4) By Application: Vaccine Production, Therapeutic Development, Drug Discovery, Other Applications
Subsegments:
1) By Messenger Ribonucleic Acid (mRNA) Drug Synthesis: Custom Messenger Ribonucleic Acid (mRNA) Synthesis, GMP-Grade Messenger Ribonucleic Acid (mRNA) Synthesis, Large-Scale Messenger Ribonucleic Acid (mRNA) Synthesis, Modified Messenger Ribonucleic Acid (mRNA) Synthesis, Capping And Tailing Services, Purification Services
2) By Messenger Ribonucleic Acid (mRNA) Vaccine Synthesis: Preclinical Messenger Ribonucleic Acid (mRNA) Vaccine Synthesis, Clinical-Grade Messenger Ribonucleic Acid (mRNA) Vaccine Synthesis, GMP-Compliant Vaccine Batch Production, Self-Amplifying Messenger Ribonucleic Acid (mRNA) Synthesis, Messenger Ribonucleic Acid (mRNA)-LNP Formulation Services For Vaccines, Stability Testing And QC Services
What Industry Trends Are Transforming The Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market?
Leading companies in the messenger ribonucleic acid (mRNA) synthesis and manufacturing market are focusing on creating innovative products, such as co-transcriptional capping platforms, to accelerate preclinical research and reduce regulatory burdens. A co-transcriptional capping platform represents a proprietary method for efficiently attaching a protective cap to messenger ribonucleic acid (mRNA) molecules during synthesis, thereby enhancing mRNA stability, translation efficiency, and immunogenicity control. For example, in May 2025, GenScript, a US-based life sciences research tools company, introduced its good manufacturing practice (GMP)-like messenger ribonucleic acid (mRNA) manufacturing service. This is a scalable, regulatory-aware manufacturing service designed to produce high-purity, functional mRNA for investigational new drug (IND)-enabling preclinical studies, including toxicology, biodistribution, and pharmacokinetics or pharmacodynamics (PK or PD) assessments. It is established within cleanroom-compliant, International Organization for Standardization (ISO) 7-classified environments and incorporates patented co-transcriptional capping technology. This service provides customized mRNA in as little as seven weeks. Such an innovation bridges the critical development gap between research-grade and full GMP manufacturing, allowing early-stage biotechnology and pharmaceutical companies to conduct regulatory-aligned studies without the significant costs and delays typically associated with traditional GMP production.
Which Major Industry Participants Are Leading The Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market Growth?
Major companies operating in the messenger ribonucleic acid (mrna) synthesis and manufacturing market are Thermo Fisher Scientific Inc., Evonik Industries AG, Moderna Inc., BioNTech SE , AGC Biologics A/S, Eurofins Scientific SE, Lonza Group AG, Catalent Inc., WuXi Biologics (Cayman) Inc., Samsung Biologics Co Ltd., GenScript Biotech Corporation, Arcturus Therapeutics Holdings Inc., New England Biolabs Inc., CureVac N.V., Abzena plc, Creative Biolabs Inc., Aldevron LLC, eTheRNA immunotherapies NV, Bio-Synthesis Inc., TriLink BioTechnologies LLC
Access The Complete Report For Deeper Market Insights:
Which Region Is Expected To Experience The Fastest Growth In The Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market?
North America was the largest region in the messenger ribonucleic acid (mRNA) synthesis and manufacturing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the messenger ribonucleic acid (mrna) synthesis and manufacturing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=25832&type=smp
Browse Through More Reports Similar to the Global Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market 2026, By The Business Research Company
Messenger Ribonucleic Acid Mrna Synthesis Raw Materials Market Report 2026
Gene Synthesis Market Report 2026
https://www.thebusinessresearchcompany.com/report/gene-synthesis-global-market-report
Mrna Therapeutics Market Report 2026
https://www.thebusinessresearchcompany.com/report/mrna-therapeutics-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
